Publications

5600 Results

Adjuvant therapy for high-risk kidney cancer: ECOG-ACRIN E2805

Authors
NB Haas;J Manola;R Uzzo;K Flaherty;C Wood;C Kane;M Jewett;J Dutcher;MB Atkins;M Pins;G Wilding;D Cella;L Wagner;S Matin;T Kuzel;W Sexton;Y Wong;T Choueiri;R Pili;R Puzanov;M Kohli;W Stadler;M Carducci;R Coomes;R Dipaola
Journal / Conference
Lancet May 14;387(10032):2008-2016; 2016 Mar 8 [Epub ahead of print]
Year
2016
Research Committee(s)
Genitourinary
PMID
PMID26969090
PMC
PMC4878938
Study Number(s)
CTSU/E2805

SWOG S0800 (NCI CDR0000636131):Addition of bevacizumab to neoadjuvant nab-paclitaxel with dose–dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer

Authors
Z Nahleh;W Barlow;D Hayes;A Schott;J Gralow;E Perez;W Sikov;S Chennuru;H Mirshahidi;S Corso;D Lew;L Pusztai;R Livingston;G Hortobagyi
Journal / Conference
Breast Cancer Research and Treatment Aug;158(3):485-495; 2016 Jul 8 [Epub ahead of print]
Year
2016
Research Committee(s)
Breast
PMID
PMID27393622
PMC
PMC4963434
Study Number(s)
S0800

Phase II studies of two different schedules of dasatinib in bone-metastasis predominant metastatic breast cancer: SWOG S0622

Authors
A Schott;W Barlow;C Van Poznak;D Hayes;C Moinpour;D Lew;C Reynolds;P Dy;E Keller;J Keller;G Hortobagyi
Journal / Conference
Breast Cancer Research and Treatment Aug;159(1):87-95; 2016 Jul 30 [Epub ahead of print]
Year
2016
Research Committee(s)
Breast
PMID
PMID27475087
PMC
PMC5021222
Study Number(s)
S0622

Molecular heterogeneity and response to neoadjuvant human epidermal growth factor receptor 2 targeting in CALGB 40601, a randomized phase III trial of paclitaxel plus trastuzumab with or without lapatinib

Authors
LA Carey;DA Berry;CT Cirrincione;WT Barry;BN Pitcher;LN Harris;DW Ollila;IE Krop;NL Henry;DJ Weckstein;CK Anders;B Singh;KA Hoadley;M Iglesia;M Cheang;C Perou;E Winer;C Hudis
Journal / Conference
Journal of Clinical Oncology, Feb 20;34(6):542-549
Year
2016
Research Committee(s)
Breast
PMID
PMID26527775
PMC
PMC4980567

Patterns of local-regional management following neoadjuvant chemotherapy in breast cancer: results from ACOSOG Z1071 (Alliance)

Authors
BG Haffty;LM McCall;KV Ballman;S McLaughlin;R Jagsi;DW Ollila;KS Hunt;TA Buchholz
Journal / Conference
International Journal of Radiation Oncology, Biology & Physics, Mar 94(3):493-502
Year
2016
Research Committee(s)
Breast
PMID
PMID26867878
PMC
PMC4752720

Identifying severe adverse event clusters using the National Cancer Institute's Common Terminology Criteria for Adverse Events

Authors
X Zhong;E Lim;DL Hershman;CM Moinpour;JM Unger;SM Lee
Journal / Conference
Journal of Oncology Practice, Mar;12(3):245-246
Year
2016
Research Committee(s)
Genitourinary
PMID
PMID26907453
PMC
PMC5702793
Study Number(s)
S9916

Addressing skyrocketing cancer drug prices comes with tradeoffs: pick your poison. [Opinion]

Authors
S Ramsey;GH Lyman;R Bangs
Journal / Conference
JAMA Oncology, Apr 1;2(4):425-426; 2016 Feb 11 [Epub ahead of print]
Year
2016
Research Committee(s)
Cancer Care Delivery
PMID
PMID26868102
PMC
PMC n/a [opinion article]

Next steps for adolescent and young adult oncology workshop: An update on progress and recommendations for the future [Review]

Authors
AW Smith;NL Seibel;DR Lewis;KH Albritton;DF Blair;CD Blanke;A Bleyer;DR Freyer;AM Geiger;B Hayes-Lattin;JV Tricoli;LI Wagner;BJ Zebrack
Journal / Conference
Cancer Apr 1;122(7):988-999
Year
2016
Research Committee(s)
Cancer Care Delivery
PMID
PMID26849003
PMC
PMC n/a - review article

Comorbidities and risk of chemotherapy induced peripheral neuropathy among participants in SWOG clinical trials

Authors
DL Hershman;C Till;JD Wright;D Awad;S Ramsey;W Barlow;L Minasian;J Unger
Journal / Conference
Journal of Clinical Oncology 34, 2016 (suppl; abstr 10001); American Society of Clinical Oncology Annual Meeting (June 3-7, 2016, Chicago, IL), oral presentation
Year
2016
Research Committee(s)
Breast, Genitourinary, Gynecologic, Head and Neck, and Lung
Study Number(s)
S0003, S0007, S0009, S0012, S0022, S0023, S0027, S0028, S0029, S0032, S0102, S0219, S0221, S0329, S0421, S0536, S0819, S9712, S9900, S9902, S9912, S9914, S9916

Azacitidine with or without entinostat for the treatment of therapy-related myeloid neoplasm: further results of the E1905 North American Leukemia Intergroup study

Authors
T Prebet;Z Sun;R Ketterling;A Zeidan;P Greenberg;J Herman;M Juckett;MR Smith;L Malick;E Paietta;M Czader;M Figueroa;J Gabrilove;H Erba;M Tallman;M Litzow;S Gore
Journal / Conference
British Journal of Haematology, Feb;172(3):384-391
Year
2016
Research Committee(s)
Leukemia
PMID
PMID26577691
PMC
PMC4794257
Study Number(s)
E1905